Information for Health Care Professionals:
The information here is provided as a service for health care providers to provide relevant pharmacological and clinical information about CVT-E002 the active ingredient of COLD-FX®. It is considered important for health care professionals to have access to full information regarding natural health products which their patients may be taking.
Each capsule of COLD-FX has been certified by ChemBioPrint® to contain 200 mg of CVT-E002, a unique proprietary aqueous extract containing greater than 80% poly-furanosyl-pyranosyl-saccharides from Panax quinquefolius (North American ginseng, root).
 |
COLD-FX is officially indicated in Canada to help reduce the frequency, severity and duration of cold and flu symptoms by boosting the immune system. It has a product license and a product number (NPN 80002849). |
 |
COLD-FX has an established efficacy and safety profile when used to help reduce the frequency, severity and duration of cold and flu symptoms by boosting the immune system. |
 |
COLD-FX efficacy and safety profiles are supported by scientific evidence including randomized, controlled trials. |
 |
Individuals requiring anti-coagulant therapy such as warfarin should avoid us of COLD-FX. Do not use if pregnant or breastfeeding. Not recommended for individuals with impaired liver or renal functions. Do not exceed the recommended daily dose. |
|
|
| |
|
| |
Learn about Health Canada's Natural Health Product Directorate and Regulations |
| |
|
 |
COLD-FX is a standardized ChemBioPrint product. ChemBioPrint signifies that a proprietary process has been used to identify, through both biological and chemical testing, the active components of CVT-E002 which provide the health benefits. The health benefits identified include CVT-E002’s ability to targeting the immune system by activating viral-fighting Natural Killer cells and macrophages. The proprietary process behind ChemBioPrint also ensures that COLD-FX is consistently made from batch to batch. |
| |
|
 |
COLD-FX is a unique formulation with patents issued and pending worldwide. Its composition, as well as pharmacology and clinical effects are distinct, and differ significantly from those of crude ginseng products. |
|